ArticleJournal of personalized medicine2021

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.

Júlia Granell-Geli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.